Clinical Impact of CDK4/6 Inhibitors in De Novo or PR− or Very Elderly Post-Menopausal ER+/HER2− Advanced Breast CancersHiu Tang, Srinivasan Madhusudan, Karen De Souza et al.|Cancers|2023Cited by 17